Orbimed Advisors Llc - Net Worth and Insider Trading

Orbimed Advisors Llc Net Worth

The estimated net worth of Orbimed Advisors Llc is at least $3.5 Billion dollars as of 2024-04-22. Orbimed Advisors Llc is the Director, 10% Owner of Synthorx Inc and owns about 5,316,355 shares of Synthorx Inc (THOR) stock worth over $361 Million. Orbimed Advisors Llc is the Director, 10% Owner of Prevail Therapeutics Inc and owns about 13,822,463 shares of Prevail Therapeutics Inc (PRVL) stock worth over $318 Million. Orbimed Advisors Llc is also the Director, 10% Owner of Edgewise Therapeutics Inc and owns about 14,756,096 shares of Edgewise Therapeutics Inc (EWTX) stock worth over $225 Million. Besides these, Orbimed Advisors Llc also holds SpringWorks Therapeutics Inc (SWTX) , Loxo Oncology Inc (LOXO) , Audentes Therapeutics Inc (BOLD) , Principia Biopharma Inc (PRNB) , Turning Point Therapeutics Inc (TPTX) , Relypsa Inc (RLYP) , Rhythm Pharmaceuticals Inc (RYTM) , Supernus Pharmaceuticals Inc (SUPN) , NxStage Medical Inc (NXTM) , ARS Pharmaceuticals Inc (SPRY) , Theseus Pharmaceuticals Inc (THRX) , Mirati Therapeutics Inc (MRTX) , CTI BioPharma Corp (CTIC) , Third Harmonic Bio Inc (THRD) , Fusion Pharmaceuticals Inc (FUSN) , Keros Therapeutics Inc (KROS) , Pacira BioSciences Inc (PCRX) , Verona Pharma PLC (VRNA) , Intellia Therapeutics Inc (NTLA) , Silverback Therapeutics Inc (SBTX) , NeuroPace Inc (NPCE) , Prelude Therapeutics Inc (PRLD) , Terns Pharmaceuticals Inc (TERN) , Dimension Therapeutics Inc (DMTX) , Compass Therapeutics Inc (CMPX) , Imara Inc (IMRA) , scPharmaceuticals Inc (SCPH) , ArriVent BioPharma Inc (AVBP) , Adicet Bio Inc (ACET) , Intercept Pharmaceuticals Inc (ICPT) , ORIC Pharmaceuticals Inc (ORIC) , Alpine Immune Sciences Inc (ALPN) , CalciMedica Inc (CALC) , 89bio Inc (ETNB) , SI-BONE Inc (SIBN) , Constellation Pharmaceuticals Inc (CNST) , TELA Bio Inc (TELA) , Janux Therapeutics Inc (JANX) , PMV Pharmaceuticals Inc (PMVP) , Corvus Pharmaceuticals Inc (CRVS) , Alector Inc (ALEC) , Passage Bio Inc (PASG) , Turnstone Biologics Corp (TSBX) , Disc Medicine Inc (IRON) , Adaptimmune Therapeutics PLC (ADAP) , NextCure Inc (NXTC) , Decibel Therapeutics Inc (DBTX) , Arcutis Biotherapeutics Inc (ARQT) , Xtant Medical Holdings Inc (XTNT) , Spyre Therapeutics Inc (SYRE) , resTORbio Inc (TORC) , Kinnate Biopharma Inc (KNTE) , Acutus Medical Inc (AFIB) , Cartesian Therapeutics Inc (RNAC) , Galecto Inc (GLTO) , Aerpio Pharmaceuticals Inc (ARPO) , LogicBio Therapeutics Inc (LOGC) , Kala Bio Inc (KALA) , Inspire Medical Systems Inc (INSP) , Repare Therapeutics Inc (RPTX) , Ikena Oncology Inc (IKNA) , Otonomy Inc (OTIC) , Sientra Inc (SIENQ) , Pieris Pharmaceuticals Inc (PIRS) , ViewRay Inc (VRAYQ) , Logic Devices Inc (LOGC) , Athersys Inc (ATHXQ) , Sorrento Tech Inc (ROKA) , SteadyMed Ltd (STDY) , Glaukos Corp (GKOS) , Tricida Inc (TCDAQ) . Details can be seen in Orbimed Advisors Llc's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Orbimed Advisors Llc has not made any transactions after 2024-04-18 and currently still holds the listed stock(s).

Transaction Summary of Orbimed Advisors Llc

To

Orbimed Advisors Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Orbimed Advisors Llc owns 92 companies in total, including Arcutis Biotherapeutics Inc () , Xtant Medical Holdings Inc () , and LogicBio Therapeutics Inc () among others .

Click here to see the complete history of Orbimed Advisors Llc’s form 4 insider trades.

Insider Ownership Summary of Orbimed Advisors Llc

Ticker Comapny Transaction Date Type of Owner
Arcutis Biotherapeutics Inc 2022-06-24 director & 10 percent owner
Xtant Medical Holdings Inc 2018-02-14 10 percent owner
LogicBio Therapeutics Inc 2020-10-01 director & 10 percent owner
CalciMedica Inc 2020-09-25 director & 10 percent owner
Prelude Therapeutics Inc 2023-05-22 director & 10 percent owner
PMV Pharmaceuticals Inc 2023-11-22 10 percent owner
89bio Inc 2022-01-26 director & 10 percent owner
Inspire Medical Systems Inc 2020-08-18 director
Acutus Medical Inc 2021-07-19 director & 10 percent owner
Pandion Therapeutics Inc 2020-07-16 10 percent owner
Fusion Pharmaceuticals Inc 2020-06-30 director
Repare Therapeutics Inc 2021-09-07 director
scPharmaceuticals Inc 2022-11-25 10 percent owner
ORIC Pharmaceuticals Inc 2021-03-30 director
Alector Inc 2020-04-16 10 percent owner
Keros Therapeutics Inc 2020-04-13 director
Imara Inc 2021-07-16 director & 10 percent owner
CTI BioPharma Corp 2021-01-07 10 percent owner
Passage Bio Inc 2023-06-28 10 percent owner
Sierra Oncology Inc 2019-11-22 director & 10 percent owner
Tricida Inc 2022-11-25 director & 10 percent owner
TELA Bio Inc 2023-04-21 10 percent owner
SpringWorks Therapeutics Inc 2022-09-12 10 percent owner
Corvus Pharmaceuticals Inc 2021-09-20 director
Prevail Therapeutics Inc 2019-06-24 director & 10 percent owner
Principia Biopharma Inc 2019-05-21 10 percent owner
NextCure Inc 2019-05-13 director & 10 percent owner
Turning Point Therapeutics Inc 2019-04-22 director
Avedro Inc 2019-02-19 10 percent owner
Alpine Immune Sciences Inc 2023-12-28 director
Synthorx Inc 2018-12-11 director & 10 percent owner
SI-BONE Inc 2018-10-19 director
Guardant Health Inc 2018-10-03 10 percent owner
Arvinas Inc 2018-09-26 10 percent owner
SteadyMed Ltd 2018-08-30 10 percent owner
ViewRay Inc 2018-08-20 director & 10 percent owner
Constellation Pharmaceuticals Inc 2018-07-23 10 percent owner
Crinetics Pharmaceuticals Inc 2018-07-17 10 percent owner
Aerpio Pharmaceuticals Inc 2020-12-08 director & 10 percent owner
ARMO BioSciences Inc 2018-06-22 director & 10 percent owner
Adaptimmune Therapeutics PLC 2018-06-06 director
Rhythm Pharmaceuticals Inc 2018-05-22 10 percent owner
Pieris Pharmaceuticals Inc 2018-04-30 director & 10 percent owner
Audentes Therapeutics Inc 2018-03-12 10 percent owner
Glaukos Corp 2018-03-06 director
Kala Bio Inc 2018-02-08 10 percent owner & other: See Remarks
Synlogic Inc 2017-08-28 director
Loxo Oncology Inc 2017-12-08 director
X4 Pharmaceuticals Inc 2017-11-15 10 percent owner
Sorrento Tech Inc 2017-10-03 10 percent owner
Spyre Therapeutics Inc 2017-02-21 10 percent owner
Nabriva Therapeutics PLC 2016-12-30 director & 10 percent owner
Response Biomedical Corp 2016-11-29 director & 10 percent owner
Relypsa Inc 2016-07-25 10 percent owner
Cartesian Therapeutics Inc 2016-06-27 director & 10 percent owner
Intellia Therapeutics Inc 2016-05-11 10 percent owner
Otonomy Inc 2015-11-30 director
Dimension Therapeutics Inc 2015-10-27 director & 10 percent owner
Sientra Inc 2015-10-12 10 percent owner
Intercept Pharmaceuticals Inc 2015-03-26 director & 10 percent owner
Mirati Therapeutics Inc 2014-07-01 10 percent owner
Acceleron Pharma Inc 2013-09-24 other: Former 10% Owner
Supernus Pharmaceuticals Inc 2013-02-13 10 percent owner
Anthera Pharmaceuticals Inc 2013-01-30 director
Amarin Corp PLC 2011-01-01 director & 10 percent owner
Pacira BioSciences Inc 2012-03-12 10 percent owner
ChemoCentryx Inc 2012-02-08 10 percent owner
Athersys Inc 2011-04-26 director & other: (1)
NxStage Medical Inc 2010-12-09 director
Kun Run Biotechnology Inc 2010-04-30 10 percent owner
Albireo Pharma Inc 2007-05-10 10 percent owner
ARYx Therapeutics Inc 2009-05-22 10 percent owner
Insulet Corp 2007-05-14 director
Aadi Bioscience Inc 2017-03-15 director & 10 percent owner
NeuroPace Inc 2023-10-03 10 percent owner
Decibel Therapeutics Inc 2021-02-17 10 percent owner
Verona Pharma PLC 2023-05-15 director & 10 percent owner
Silverback Therapeutics Inc 2020-12-08 director & 10 percent owner
Edgewise Therapeutics Inc 2024-01-23 director & 10 percent owner
Adicet Bio Inc 2024-01-25 director & 10 percent owner
Compass Therapeutics Inc 2022-11-08 director & 10 percent owner
Theseus Pharmaceuticals Inc 2023-07-17 director & 10 percent owner
Kinnate Biopharma Inc 2023-05-05 director
Galecto Inc 2023-08-15 director & 10 percent owner
Disc Medicine Inc 2023-12-18 director & 10 percent owner
Janux Therapeutics Inc 2021-12-29 director
Terns Pharmaceuticals Inc 2022-12-23 director & 10 percent owner
Ikena Oncology Inc 2021-03-30 director
Third Harmonic Bio Inc 2022-09-19 director & 10 percent owner
ARS Pharmaceuticals Inc 2023-08-29 director
Enliven Therapeutics Inc 2020-03-11 director & 10 percent owner
Turnstone Biologics Corp 2023-07-20 director & 10 percent owner

Orbimed Advisors Llc Latest Holdings Summary

Orbimed Advisors Llc currently owns a total of 74 stocks. Among these stocks, Orbimed Advisors Llc owns 5,316,355 shares of Synthorx Inc (THOR) as of December 11, 2018, with a value of $361 Million and a weighting of 10.37%. Orbimed Advisors Llc owns 13,822,463 shares of Prevail Therapeutics Inc (PRVL) as of June 24, 2019, with a value of $318 Million and a weighting of 9.12%. Orbimed Advisors Llc also owns 14,756,096 shares of Edgewise Therapeutics Inc (EWTX) as of January 23, 2024, with a value of $225 Million and a weighting of 6.45%. The other 71 stocks SpringWorks Therapeutics Inc (SWTX) , Loxo Oncology Inc (LOXO) , Audentes Therapeutics Inc (BOLD) , Principia Biopharma Inc (PRNB) , Turning Point Therapeutics Inc (TPTX) , Relypsa Inc (RLYP) , Rhythm Pharmaceuticals Inc (RYTM) , Supernus Pharmaceuticals Inc (SUPN) , NxStage Medical Inc (NXTM) , ARS Pharmaceuticals Inc (SPRY) , Theseus Pharmaceuticals Inc (THRX) , Mirati Therapeutics Inc (MRTX) , CTI BioPharma Corp (CTIC) , Third Harmonic Bio Inc (THRD) , Fusion Pharmaceuticals Inc (FUSN) , Keros Therapeutics Inc (KROS) , Pacira BioSciences Inc (PCRX) , Verona Pharma PLC (VRNA) , Intellia Therapeutics Inc (NTLA) , Silverback Therapeutics Inc (SBTX) , NeuroPace Inc (NPCE) , Prelude Therapeutics Inc (PRLD) , Terns Pharmaceuticals Inc (TERN) , Dimension Therapeutics Inc (DMTX) , Compass Therapeutics Inc (CMPX) , Imara Inc (IMRA) , scPharmaceuticals Inc (SCPH) , ArriVent BioPharma Inc (AVBP) , Adicet Bio Inc (ACET) , Intercept Pharmaceuticals Inc (ICPT) , ORIC Pharmaceuticals Inc (ORIC) , Alpine Immune Sciences Inc (ALPN) , CalciMedica Inc (CALC) , 89bio Inc (ETNB) , SI-BONE Inc (SIBN) , Constellation Pharmaceuticals Inc (CNST) , TELA Bio Inc (TELA) , Janux Therapeutics Inc (JANX) , PMV Pharmaceuticals Inc (PMVP) , Corvus Pharmaceuticals Inc (CRVS) , Alector Inc (ALEC) , Passage Bio Inc (PASG) , Turnstone Biologics Corp (TSBX) , Disc Medicine Inc (IRON) , Adaptimmune Therapeutics PLC (ADAP) , NextCure Inc (NXTC) , Decibel Therapeutics Inc (DBTX) , Arcutis Biotherapeutics Inc (ARQT) , Xtant Medical Holdings Inc (XTNT) , Spyre Therapeutics Inc (SYRE) , resTORbio Inc (TORC) , Kinnate Biopharma Inc (KNTE) , Acutus Medical Inc (AFIB) , Cartesian Therapeutics Inc (RNAC) , Galecto Inc (GLTO) , Aerpio Pharmaceuticals Inc (ARPO) , LogicBio Therapeutics Inc (LOGC) , Kala Bio Inc (KALA) , Inspire Medical Systems Inc (INSP) , Repare Therapeutics Inc (RPTX) , Ikena Oncology Inc (IKNA) , Otonomy Inc (OTIC) , Sientra Inc (SIENQ) , Pieris Pharmaceuticals Inc (PIRS) , ViewRay Inc (VRAYQ) , Logic Devices Inc (LOGC) , Athersys Inc (ATHXQ) , Sorrento Tech Inc (ROKA) , SteadyMed Ltd (STDY) , Glaukos Corp (GKOS) , Tricida Inc (TCDAQ) have a combined weighting of 74.07% among all his current holdings.

Latest Holdings of Orbimed Advisors Llc

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
THOR Synthorx Inc 2018-12-11 5,316,355 67.99 361,458,976
PRVL Prevail Therapeutics Inc 2019-06-24 13,822,463 23.00 317,916,649
EWTX Edgewise Therapeutics Inc 2024-01-23 14,756,096 15.23 224,735,342
SWTX SpringWorks Therapeutics Inc 2022-09-12 5,599,842 40.06 224,329,671
LOXO Loxo Oncology Inc 2017-12-08 941,000 234.66 220,815,060
BOLD Audentes Therapeutics Inc 2018-03-12 3,539,997 59.97 212,293,620
PRNB Principia Biopharma Inc 2019-05-21 1,605,713 100.05 160,651,586
TPTX Turning Point Therapeutics Inc 2019-04-22 2,027,550 76.01 154,114,076
RLYP Relypsa Inc 2016-07-25 3,356,400 31.99 107,371,236
RYTM Rhythm Pharmaceuticals Inc 2018-05-22 2,750,079 38.01 104,530,503
SUPN Supernus Pharmaceuticals Inc 2013-02-13 3,000,000 29.42 88,260,000
NXTM NxStage Medical Inc 2010-12-09 2,690,476 30.00 80,714,280
SPRY ARS Pharmaceuticals Inc 2023-08-29 9,240,887 8.47 78,270,313
THRX Theseus Pharmaceuticals Inc 2023-07-17 17,713,600 4.06 71,917,216
MRTX Mirati Therapeutics Inc 2014-07-01 1,167,000 58.70 68,502,900
CTIC CTI BioPharma Corp 2021-01-07 7,520,600 9.09 68,362,254
THRD Third Harmonic Bio Inc 2022-09-19 5,779,071 11.67 67,441,759
FUSN Fusion Pharmaceuticals Inc 2020-06-30 3,122,770 21.26 66,390,090
KROS Keros Therapeutics Inc 2020-04-13 1,119,812 58.44 65,441,813
PCRX Pacira BioSciences Inc 2012-03-12 2,446,000 26.25 64,207,500
VRNA Verona Pharma PLC 2023-05-15 3,777,778 15.72 59,386,670
NTLA Intellia Therapeutics Inc 2016-05-11 2,662,180 21.59 57,476,466
SBTX Silverback Therapeutics Inc 2020-12-08 8,740,888 5.87 51,309,013
NPCE NeuroPace Inc 2024-04-18 3,501,975 13.97 48,922,591
PRLD Prelude Therapeutics Inc 2023-05-22 10,646,056 3.71 39,496,868
TERN Terns Pharmaceuticals Inc 2022-12-23 7,619,135 4.56 34,743,256
DMTX Dimension Therapeutics Inc 2015-10-27 5,397,698 5.95 32,116,303
CMPX Compass Therapeutics Inc 2022-11-08 18,791,422 1.47 27,623,390
IMRA Imara Inc 2021-07-16 4,199,068 6.32 26,538,110
SCPH scPharmaceuticals Inc 2022-11-25 5,559,528 4.56 25,351,448
AVBP ArriVent BioPharma Inc 2024-01-30 1,513,664 15.45 23,386,109
ACET Adicet Bio Inc 2024-01-25 11,447,140 1.95 22,264,687
ICPT Intercept Pharmaceuticals Inc 2015-03-26 1,120,324 19.00 21,286,156
ORIC ORIC Pharmaceuticals Inc 2021-03-30 2,212,571 9.20 20,355,653
ALPN Alpine Immune Sciences Inc 2023-12-28 264,315 64.54 17,058,890
CALC CalciMedica Inc 2020-09-25 4,163,347 4.01 16,695,021
ETNB 89bio Inc 2022-01-26 1,829,436 9.09 16,629,573
SIBN SI-BONE Inc 2018-10-19 985,368 15.43 15,204,228
CNST Constellation Pharmaceuticals Inc 2018-07-23 417,921 33.99 14,205,135
TELA TELA Bio Inc 2023-04-21 2,835,542 4.75 13,468,825
JANX Janux Therapeutics Inc 2021-12-29 231,098 48.69 11,252,162
PMVP PMV Pharmaceuticals Inc 2023-11-22 6,475,291 1.62 10,489,971
CRVS Corvus Pharmaceuticals Inc 2021-09-20 6,943,654 1.42 9,859,989
ALEC Alector Inc 2020-04-16 1,906,718 5.10 9,724,262
PASG Passage Bio Inc 2023-06-28 8,034,000 1.15 9,239,100
TSBX Turnstone Biologics Corp 2023-07-20 3,099,265 2.60 8,058,089
IRON Disc Medicine Inc 2023-12-18 224,405 28.69 6,438,179
ADAP Adaptimmune Therapeutics PLC 2018-06-06 4,901,310 0.98 4,787,109
NXTC NextCure Inc 2019-05-13 2,711,013 1.60 4,337,621
DBTX Decibel Therapeutics Inc 2021-02-17 883,418 4.91 4,337,582
ARQT Arcutis Biotherapeutics Inc 2022-06-24 415,142 9.10 3,777,792
XTNT Xtant Medical Holdings Inc 2018-02-14 3,316,128 0.83 2,752,386
SYRE Spyre Therapeutics Inc 2017-02-21 58,781 32.28 1,897,451
TORC resTORbio Inc 2018-01-30 690,055 2.28 1,573,325
KNTE Kinnate Biopharma Inc 2023-05-05 450,000 2.65 1,192,500
AFIB Acutus Medical Inc 2021-07-19 6,553,408 0.17 1,114,407
RNAC Cartesian Therapeutics Inc 2016-06-27 60,847 17.85 1,086,119
GLTO Galecto Inc 2023-08-15 1,510,375 0.68 1,029,321
ARPO Aerpio Pharmaceuticals Inc 2020-12-08 346,265 2.20 761,783
LOGC LogicBio Therapeutics Inc 2020-10-01 296,296 2.07 613,333
KALA Kala Bio Inc 2018-02-08 68,957 6.59 454,427
INSP Inspire Medical Systems Inc 2020-08-18 1,784 229.22 408,928
RPTX Repare Therapeutics Inc 2021-09-07 96,190 3.14 302,037
IKNA Ikena Oncology Inc 2021-03-30 130,924 1.33 174,129
OTIC Otonomy Inc 2015-11-30 1,850,094 0.01 15,726
SIENQ Sientra Inc 2015-10-12 178,500 0.07 11,781
PIRS Pieris Pharmaceuticals Inc 2018-04-30 38,870 0.15 5,640
VRAYQ ViewRay Inc 2018-08-20 69,617 0.00 1
LOGC Logic Devices Inc 2018-10-23 6,466,783 0.00 0
ATHXQ Athersys Inc 2011-04-26 0 0.00 0
ROKA Sorrento Tech Inc 2017-10-03 0 0.65 0
STDY SteadyMed Ltd 2018-08-30 0 4.73 0
GKOS Glaukos Corp 2018-03-06 0 96.50 0
TCDAQ Tricida Inc 2022-11-25 0 0.00 0

Holding Weightings of Orbimed Advisors Llc


Orbimed Advisors Llc Form 4 Trading Tracker

According to the SEC Form 4 filings, Orbimed Advisors Llc has made a total of 0 transactions in Synthorx Inc (THOR) over the past 5 years. The most-recent trade in Synthorx Inc is the acquisition of 1,363,636 shares on December 11, 2018, which cost Orbimed Advisors Llc around $15 Million.

According to the SEC Form 4 filings, Orbimed Advisors Llc has made a total of 1 transactions in Prevail Therapeutics Inc (PRVL) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Prevail Therapeutics Inc is the acquisition of 882,352 shares on June 24, 2019, which cost Orbimed Advisors Llc around $15 Million.

According to the SEC Form 4 filings, Orbimed Advisors Llc has made a total of 4 transactions in Edgewise Therapeutics Inc (EWTX) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Edgewise Therapeutics Inc is the acquisition of 454,545 shares on January 23, 2024, which cost Orbimed Advisors Llc around $5 Million.

More details on Orbimed Advisors Llc's insider transactions can be found in the Insider Trading History of Orbimed Advisors Llc table.

Insider Trading History of Orbimed Advisors Llc

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Orbimed Advisors Llc Trading Performance

GuruFocus tracks the stock performance after each of Orbimed Advisors Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Orbimed Advisors Llc is 9.88%. GuruFocus also compares Orbimed Advisors Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Orbimed Advisors Llc within 3 months outperforms 64 times out of 114 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Orbimed Advisors Llc's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Orbimed Advisors Llc

Average Return

-2.01%

Average return per transaction

Outperforming Transactions

36%

38 out of 106 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 3.27 9.88 1.87 -2.01 -9.27 -12.27
Relative Return to S&P 500(%) 2.75 7.31 -2.81 -12.47 -19.19 -23.48

Orbimed Advisors Llc Ownership Network

Ownership Network List of Orbimed Advisors Llc

No Data

Ownership Network Relation of Orbimed Advisors Llc


Orbimed Advisors Llc Owned Company Details

What does Arcutis Biotherapeutics Inc do?

Who are the key executives at Arcutis Biotherapeutics Inc?

Orbimed Advisors Llc is the director & 10 percent owner of Arcutis Biotherapeutics Inc. Other key executives at Arcutis Biotherapeutics Inc include director & 10 percent owner Patrick J Heron , SVP and Chief Business Officer Matthew Richard Moore , and director & President and CEO Todd Franklin Watanabe .

Arcutis Biotherapeutics Inc () Insider Trades Summary

Over the past 18 months, Orbimed Advisors Llc made no insider transaction in Arcutis Biotherapeutics Inc (). Other recent insider transactions involving Arcutis Biotherapeutics Inc () include a net sale of 30,155 shares made by Todd Franklin Watanabe , a net sale of 37,403 shares made by Howard G. Welgus , and a net sale of 10,594 shares made by Masaru Matsuda .

In summary, during the past 3 months, insiders sold 29,378 shares of Arcutis Biotherapeutics Inc () in total and bought 21,052 shares, with a net sale of 8,326 shares. During the past 18 months, 104,916 shares of Arcutis Biotherapeutics Inc () were sold and 102,515 shares were bought by its insiders, resulting in a net sale of 2,401 shares.

Arcutis Biotherapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Arcutis Biotherapeutics Inc Insider Transactions

No Available Data

Orbimed Advisors Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Orbimed Advisors Llc. You might contact Orbimed Advisors Llc via mailing address: 601 Lexington Avenue, 54th Floor, New York Ny 10022.

Discussions on Orbimed Advisors Llc

No discussions yet.